In recent articles, I have argued for an approach to presbyopia correction that selects a presbyopic IOL according to each patient’s unique presbyopia profile. In my experience, this customized ...
NEW YORK--(BUSINESS WIRE)-- Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP™) therapeutics, today announced ...
LENZ Therapeutics and Lunatus Marketing & Consulting FZCO recently announced an exclusive agreement for Lunatus to register ...
Please provide your email address to receive an email when new articles are posted on . Staff can be trained to collect information about patients’ lifestyles from ...
A Prescription Drug User Fee Act target date of January 28, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for Brimochol ™ ...
Deseyne ® (vifilcon C) Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia with Extended Depth of Focus (EDOF) Delivers Continuous Vision at All Distances—Redefining Presbyopia Correction ...
The US. Food and Drug Administration (FDA) has officially cleared Deseyne contact lenses, developed by Bruno Vision Care, for ...
Presbyopia affects approximately 90% of adults in the U.S. over age 45, causing blurred near vision and eye strain, particularly in dim lighting. "We are pleased with the positive results from the ...
Launched VIZZ™ (aceclidine ophthalmic solution) 1.44% in October 2025 for the treatment of presbyopia, with broad product availability in ...
SAN DIEGO — An experimental combination of drugs can temporarily correct the vision of people with presbyopia, a new study shows. "With one drop in the morning, you don't need glasses all day," said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback